...
首页> 外文期刊>Nature Communications >Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening
【24h】

Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening

机译:使用自动化的DNA编码文库筛选,同时优先处理多个治疗靶标

获取原文
           

摘要

The identification and prioritization of chemically tractable therapeutic targets is a significant challenge in the discovery of new medicines. We have developed a novel method that rapidly screens multiple proteins in parallel using DNA-encoded library technology (ELT). Initial efforts were focused on the efficient discovery of antibacterial leads against 119 targets from Acinetobacter baumannii and Staphylococcus aureus . The success of this effort led to the hypothesis that the relative number of ELT binders alone could be used to assess the ligandability of large sets of proteins. This concept was further explored by screening 42 targets from Mycobacterium tuberculosis . Active chemical series for six targets from our initial effort as well as three chemotypes for DHFR from M. tuberculosis are reported. The findings demonstrate that parallel ELT selections can be used to assess ligandability and highlight opportunities for successful lead and tool discovery.
机译:化学上易于治疗的治疗靶标的鉴定和优先次序是新药发现中的重大挑战。我们已经开发出一种新颖的方法,可以使用DNA编码文库技术(ELT)快速并行地筛选多种蛋白质。最初的努力集中于有效发现针对鲍曼不动杆菌和金黄色葡萄球菌的119个靶标的抗菌肽。这项工作的成功导致了这样一个假设,即仅ELT结合剂的相对数量可用于评估大组蛋白质的配体能力。从结核分枝杆菌中筛选出42个靶标,进一步探索了这个概念。据报道,从我们最初的努力中可以找到六个目标的活性化学系列,以及来自结核分枝杆菌的DHFR的三种化学型。研究结果表明,平行ELT选择可用于评估配体能力,并突出显示成功进行铅和工具发现的机会。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号